Migraines, a common health issue that affects millions of people worldwide, are about to meet a formidable opponent. The National Institute for Health and Care Excellence (NICE) in the UK has recommended a new drug, Rimegepant, for preventing migraines. This groundbreaking treatment, also known as Vydura, is manufactured by Pfizer and is taken as a wafer that dissolves under the tongue.
Headache
Headache is a pain in the head and neck region that may be either a disorder in its own right or a symptom of an underlying medical condition or disease. The medical term for headache is cephalalgia.
Tick Talk: The Rise and Spread of Babesiosis in America
A new report from the CDC says that a disease called babesiosis, which is spread by ticks, has become more common in the United States
Azedra injection – first treatment approved for rare adrenal tumors
The U.S. Food and Drug Administration approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and
High blood pressure may not necessarily an emergency
Visits to emergency departments for patients with hypertension increased by 64 percent between 2002 and 2012 while hospitalizations for those visits declined by 28 percent.
Anthim injection approved to treat inhalational anthrax
U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent
ReShape balloon device to treat obesity approved in US
The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) – A new balloon device to treat obesity without the need for invasive surgery is approved
Provenge – Sipuleucel-T may have added benefit in prostate cancer
Sipuleucel-T in prostate cancer: Indication of added benefit – Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
Chronic fatigue syndrome is not psychological disease
Scientists discover robust evidence that chronic fatigue syndrome is a biological illness – Immune signatures in blood point to distinct disease stages, open door to better diagnosis and treatment – Researchers identified distinct immune changes in patients diagnosed with chronic fatigue syndrome, known medically as myalgic encephalomyelitis (ME/CFS) or systemic exertion intolerance disease.
Chobani yogurt recalled – 170 fell sick
170 reportedly sickened by mold in Chobani yogurt – Complaints double from people attributing sickness to Chobani yogurt – As of September 13, the FDA received a total of 170 complaints associated with Chobani. The various issues reported continue to be cramps, nausea, headache and diarrhea. The complaints were submitted by individuals in Arizona, Delaware, New York, Maryland, Ohio, Pennsylvania, California, Indiana and Florida.
Acetaminophen pain drug can cause rare serious skin reactions
FDA Warns of Rare Acetaminophen Risk — Acetaminophen linked to three serious skin diseases – Acetaminophen, a fever and pain reliever that is one of the most widely used medicines in the U.S., can cause rare but serious skin reactions, warns the Food and Drug Administration (FDA).